Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Icaritin Exacerbates Mitophagy and Synergizes with Doxorubicin to Induce Immunogenic Cell Death in Hepatocellular Carcinoma
Zhuo Yu, Jianfeng Guo, Mengying Hu, et al.
ACS Nano (2020) Vol. 14, Iss. 4, pp. 4816-4828
Open Access | Times Cited: 330

Showing 1-25 of 330 citing articles:

An ER‐Targeting Iridium(III) Complex That Induces Immunogenic Cell Death in Non‐Small‐Cell Lung Cancer
Lili Wang, Ruilin Guan, Lina Xie, et al.
Angewandte Chemie International Edition (2020) Vol. 60, Iss. 9, pp. 4657-4665
Closed Access | Times Cited: 207
Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)
Jian Zhou, Hui‐Chuan Sun, Zheng Wang, et al.
Liver Cancer (2023) Vol. 12, Iss. 5, pp. 405-444
Open Access | Times Cited: 191
A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer
Dandan Sun, Yifang Zou, Song Liu, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 1, pp. 378-393
Open Access | Times Cited: 127
Anti-inflammatory and immunoregulatory effects of icariin and icaritin
Zhangyang Bi, Wei Zhang, Xiaoyan Yan
Biomedicine & Pharmacotherapy (2022) Vol. 151, pp. 113180-113180
Open Access | Times Cited: 125
Nitric Oxide Induces Immunogenic Cell Death and Potentiates Cancer Immunotherapy
Wei Jiang, Wang Dong, Min Li, et al.
ACS Nano (2022) Vol. 16, Iss. 3, pp. 3881-3894
Closed Access | Times Cited: 124
Two nanoformulations induce reactive oxygen species and immunogenetic cell death for synergistic chemo-immunotherapy eradicating colorectal cancer and hepatocellular carcinoma
Jianfeng Guo, Zhuo Yu, Dandan Sun, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 116
d -lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma
Shulan Han, Xueying Bao, Yifang Zou, et al.
Science Advances (2023) Vol. 9, Iss. 29
Open Access | Times Cited: 106
Multidisciplinary strategies to enhance therapeutic effects of flavonoids from Epimedii Folium: Integration of herbal medicine, enzyme engineering, and nanotechnology
Yi Lu, Qiulan Luo, Xiaobin Jia, et al.
Journal of Pharmaceutical Analysis (2022) Vol. 13, Iss. 3, pp. 239-254
Open Access | Times Cited: 100
Drug-induced oxidative stress in cancer treatments: Angel or devil?
Hao Jiang, Jing Zuo, Bowen Li, et al.
Redox Biology (2023) Vol. 63, pp. 102754-102754
Open Access | Times Cited: 100
Intravenous Delivery of Living Listeria monocytogenes Elicits Gasdmermin-Dependent Tumor Pyroptosis and Motivates Anti-Tumor Immune Response
Yao Liu, Yiping Lu, Bo Ning, et al.
ACS Nano (2022) Vol. 16, Iss. 3, pp. 4102-4115
Closed Access | Times Cited: 94
Mecheliolide elicits ROS-mediated ERS driven immunogenic cell death in hepatocellular carcinoma
Zhongren Xu, Jianqiang Xu, Shibo Sun, et al.
Redox Biology (2022) Vol. 54, pp. 102351-102351
Open Access | Times Cited: 86
Advancement of cancer immunotherapy using nanoparticles-based nanomedicine
Vemana Gowd, Anas Ahmad, Mohammad Tarique, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 624-644
Closed Access | Times Cited: 83
Extracellular‐Vesicle‐Based Drug Delivery Systems for Enhanced Antitumor Therapies through Modulating the Cancer‐Immunity Cycle
Tuying Yong, Zhaohan Wei, Lu Gan, et al.
Advanced Materials (2022) Vol. 34, Iss. 52
Closed Access | Times Cited: 82
Nano delivery of simvastatin targets liver sinusoidal endothelial cells to remodel tumor microenvironment for hepatocellular carcinoma
Zhuo Yu, Jianfeng Guo, Yun Liu, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 73
Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: An update review
Jiaqi Zhai, Xi Gu, Yang Liu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 58
Exploring pharmacological active ingredients of traditional Chinese medicine by pharmacotranscriptomic map in ITCM
Sai Tian, Jinbo Zhang, Shunling Yuan, et al.
Briefings in Bioinformatics (2023) Vol. 24, Iss. 2
Closed Access | Times Cited: 57
Nano Delivery of Chemotherapeutic ICD Inducers for Tumor Immunotherapy
Jianfeng Guo, Yifang Zou, Leaf Huang
Small Methods (2023) Vol. 7, Iss. 5
Closed Access | Times Cited: 55
Augmenting Cancer Therapy with a Supramolecular Immunogenic Cell Death Inducer: A Lysosome-Targeted NIR-Light-Activated Ruthenium(II) Metallacycle
Le Tu, Chonglu Li, Qihang Ding, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 13, pp. 8991-9003
Closed Access | Times Cited: 46
m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism
Shiwei Yue, Hailing Liu, Hong-Fei Su, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 44
Enhancing in situ cancer vaccines using delivery technologies
Ningqiang Gong, Mohamad‐Gabriel Alameh, Rakan El‐Mayta, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 8, pp. 607-625
Closed Access | Times Cited: 28
Mitochondrial Localized In Situ Self‐Assembly Reprogramming Tumor Immune and Metabolic Microenvironment for Enhanced Cancer Therapy
Zhilong Wang, Qian Wang, Hongmei Cao, et al.
Advanced Materials (2024) Vol. 36, Iss. 15
Closed Access | Times Cited: 26
Advanced strategies for combinational immunotherapy of cancer based on polymeric nanomedicines
Kaisheng You, Qi Wang, Mohamed Syazwan Osman, et al.
BMEMat (2024) Vol. 2, Iss. 2
Open Access | Times Cited: 23
Icaritin with autophagy/mitophagy inhibitors synergistically enhances anticancer efficacy and apoptotic effects through PINK1/Parkin-mediated mitophagy in hepatocellular carcinoma
Piao Luo, Yehai An, Jingqian He, et al.
Cancer Letters (2024) Vol. 587, pp. 216621-216621
Closed Access | Times Cited: 21
Parkin modulates the hepatocellular carcinoma microenvironment by regulating PD-1/PD-L1 signalling
Guiqin Ye, Xin Sun, Jiuzhou Li, et al.
Journal of Advanced Research (2025)
Open Access | Times Cited: 2
Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy
Xianbin Ma, Shao‐Chen Yang, Tian Zhang, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 1, pp. 451-466
Open Access | Times Cited: 96
Page 1 - Next Page

Scroll to top